Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cesarean Hysterectomy and Uterine-Preserving Alternatives.

Huls CK.

Obstet Gynecol Clin North Am. 2016 Sep;43(3):517-38. doi: 10.1016/j.ogc.2016.04.010. Review.

PMID:
27521882
2.

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.

Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A.

PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun.

3.

Conservative management of morbidly adherent placenta: expert review.

Fox KA, Shamshirsaz AA, Carusi D, Secord AA, Lee P, Turan OM, Huls C, Abuhamad A, Simhan H, Barton J, Wright J, Silver R, Belfort MA.

Am J Obstet Gynecol. 2015 Dec;213(6):755-60. doi: 10.1016/j.ajog.2015.04.034. Epub 2015 Apr 30. Review.

PMID:
25935779
4.

Center of excellence for placenta accreta.

Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, Belfort MA, Wright JD.

Am J Obstet Gynecol. 2015 May;212(5):561-8. doi: 10.1016/j.ajog.2014.11.018. Epub 2014 Nov 20. Review.

PMID:
25460838
5.

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Graham S, Ye S, Qian M, Sanford AR, Di Tullio MR, Sacco RL, Mann DL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Labovitz AJ, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators..

PLoS One. 2014 Nov 26;9(11):e113447. doi: 10.1371/journal.pone.0113447. eCollection 2014.

6.

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S; WARCEF Investigators..

Cerebrovasc Dis. 2014;38(3):176-81. doi: 10.1159/000365502. Epub 2014 Oct 9.

7.

The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.

Olling A, Hüls C, Goy S, Müller M, Krooss S, Rudolf I, Tatge H, Gerhard R.

Toxins (Basel). 2014 Jul 22;6(7):2162-76. doi: 10.3390/toxins6072162.

8.

RNA/DNA co-analysis from human menstrual blood and vaginal secretion stains: results of a fourth and fifth collaborative EDNAP exercise.

Haas C, Hanson E, Anjos MJ, Ballantyne KN, Banemann R, Bhoelai B, Borges E, Carvalho M, Courts C, De Cock G, Drobnic K, Dötsch M, Fleming R, Franchi C, Gomes I, Hadzic G, Harbison SA, Harteveld J, Hjort B, Hollard C, Hoff-Olsen P, Hüls C, Keyser C, Maroñas O, McCallum N, Moore D, Morling N, Niederstätter H, Noël F, Parson W, Phillips C, Popielarz C, Roeder AD, Salvaderi L, Sauer E, Schneider PM, Shanthan G, Court DS, Turanská M, van Oorschot RA, Vennemann M, Vidaki A, Zatkalíková L, Ballantyne J.

Forensic Sci Int Genet. 2014 Jan;8(1):203-12. doi: 10.1016/j.fsigen.2013.09.009. Epub 2013 Oct 5.

PMID:
24315610
9.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators..

N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2.

10.

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C, Zetterberg H, Minthon L, Wallin AK, Andreasen N, Talesa VN, Blennow K.

Acta Neurol Scand. 2011 Aug;124(2):122-9. doi: 10.1111/j.1600-0404.2010.01435.x. Epub 2010 Sep 29.

PMID:
20880294
11.

GABA agonists and gabapentin for spastic hypertonia.

Francisco GE, Kothari S, Huls C.

Phys Med Rehabil Clin N Am. 2001 Nov;12(4):875-88, viii. Review.

PMID:
11723868
12.

The future of biotechnology in Europe.

Hüls C, Müllner S.

Arzneimittelforschung. 1997 Feb;47(2):233-6.

PMID:
9079244
13.

Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.

Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP.

J Infect Dis. 1995 Aug;172(2):599-602.

PMID:
7622915
14.

Expression of interleukin 10 in human melanoma.

Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T.

Br J Cancer. 1994 Dec;70(6):1182-5.

15.

A sensitive and specific bioassay for the detection of human interleukin-10.

Schlaak JF, Schmitt E, Hüls C, Meyer zum Büschenfelde KH, Fleischer B.

J Immunol Methods. 1994 Jan 12;168(1):49-54.

PMID:
8288894
16.

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.

Richter G, Krüger-Krasagakes S, Hein G, Hüls C, Schmitt E, Diamantstein T, Blankenstein T.

Cancer Res. 1993 Sep 15;53(18):4134-7.

17.

Pharmacokinetics of cefepime in cystic fibrosis patients.

Huls CE, Prince RA, Seilheimer DK, Bosso JA.

Antimicrob Agents Chemother. 1993 Jul;37(7):1414-6.

Supplemental Content

Loading ...
Support Center